Hong Chen

Has grant

Professor of Surgery

Boston Children's Hospital/Harvard Medical School
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for Atherosclerosis

Open Date: 2025-09-15

Close Date: 2029-06-30

Grant: Open

Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia

Open Date: 2024-07-08

Close Date: 2028-06-30

Grant: Open

Targeting Epsins to Develop Therapeutics for Familial Hypercholesterolemia

Open Date: 2024-07-01

Close Date: 2027-06-30

Grant: Close

The Pro-angiogenic Molecular Mechanisms Controlling Cardiovascular Diseases

Open Date: 2023-07-01

Close Date: 2026-06-30

Grant: Open

The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis

Open Date: 2021-12-01

Close Date: 2026-11-30

Articles (20)

Year:

2026

Year:

2025

Cell-cell communication (CCC) is crucial for cellular function and tissue homeostasis. Existing methods for protein-oriented CCC detection often overlook metabolite-mediated CCC (mCCC), and adapting them to mCCC analysis is challenging due to fundamental differences in the underlying biological mechanisms. To fill this gap, we developed MEBOCOST, an algorithm built on scRNA-seq and metabolic flux balance analysis to detect mCCC among single cells. Comprehensive benchmarking analyses based on simulation, spatial, CRISPR screen, and clinical patient data demonstrated the robustness of MEBOCOST in detecting biologically significant mCCC events. We applied MEBOCOST to scRNA-seq datasets of human white adipose tissues and unraveled macrophages were the predominant source of mCCC reprogramming in obese patients. Moreover, analysis in mice brown adipose tissue successfully recapitulated known and further uncovered new mCCC events, including a glutamine-mediated endothelial-to-adipocyte communication, which was experimentally verified to regulate adipocyte differentiation. Therefore, MEBOCOST is a valuable tool for researchers investigating mCCC in diverse biological contexts and disease samples. MEBOCOST is freely available at https://github.com/kaifuchenlab/MEBOCOST.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

BACKGROUND: Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipid-laden foam cells and plaques within the arterial wall. Dysfunctional vascular smooth muscle cells (VSMCs), fibroblasts, endothelial cells, and macrophages contribute to disease progression. Here, we report that macrophage-specific expression of epsins, highly conserved endocytic adaptor proteins involved in clathrin-mediated endocytosis, accelerates atherosclerosis in Western diet–fed mice. METHODS: WT/Apoe −/− (wild-type/Apoe-deficient) mice and littermates with a LysM-DKO/Apoe −/− (myeloid-specific deletion of epsin 1/2 on an Apoe −/− background) were generated and fed a Western diet for 16 weeks. Single-cell RNA sequencing was conducted to investigate the cellular and molecular mechanisms regulated by macrophage epsins during atherosclerosis. Findings from single-cell RNA sequencing were validated through metabolic profiling, qRT-PCR (quantitative reverse transcription polymerase chain reaction), immunostaining, and coculture experiments to assess associated phenotypic changes. RESULTS: LysM-DKO/Apoe −/− mice exhibited significantly reduced atherosclerotic foam cell formation compared with WT/Apoe −/− controls. Single-cell RNA sequencing analysis identified 19 major cell types, including 6 VSMC and 5 macrophage subpopulations. Modulated VSMC1 and VSMC2 subtypes were associated with inflammation, migration, and VSMC-to-macrophage transition. These populations, along with foamy-Trem2 and inflammatory macrophages, were markedly reduced in LysM-DKO/Apoe −/− mice. Transition of modulated VSMC2 subtype into macrophages was significantly inhibited, as confirmed by both computational analysis and experimental validation. In addition, macrophage epsin deletion reversed endothelial dysfunction, suppressed cholesterol- and glucose-mediated signaling, and reduced expression of proinflammatory ligands IL (interleukin)-1β and TNF-α (tumor necrosis factor α). CONCLUSIONS: Macrophage epsin deletion limits foam cell formation and preserves VSMC and endothelial cell phenotypes and functions. These findings reveal a potential therapeutic strategy targeting macrophage epsins to combat atherosclerosis.

Year:

2025

Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/− mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.

Year:

2025

Deciphering cell identity genes is pivotal to understanding cell differentiation, development, and cell identity dysregulation involving diseases. Here, we introduce SCIG, a machine-learning method to uncover cell identity genes in single cells. In alignment with recent reports that cell identity genes (CIGs) are regulated with unique epigenetic signatures, we found CIGs exhibit distinctive genetic sequence signatures, e.g. unique enrichment patterns of cis-regulatory elements. Using these genetic sequence signatures, along with gene expression information from single-cell RNA-seq data, SCIG uncovers the identity genes of a cell without a need for comparison to other cells. CIG score defined by SCIG surpassed expression value in network analysis to reveal the master transcription factors (TFs) regulating cell identity. Applying SCIG to the human endothelial cell atlas revealed that the tissue microenvironment is a critical supplement to master TFs for cell identity refinement. SCIG is publicly available at https://doi.org/10.5281/zenodo.14726426 , offering a valuable tool for advancing cell differentiation, development, and regenerative medicine research.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Yao Wei Lu

Assistant Professor

University of Southern California

UNITED STATES
View details

Daniel L. Kiss

Assistant Professor

Houston Methodist

UNITED STATES
View details

Duc-Huy Nguyen

Assistant Professor

University of Wisconsin-Madison

UNITED STATES
View details

Douglas Cowan

Staff Scientist

Boston Children's Hospital

UNITED STATES
View details

Kui Cui

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Margreet de Vries

Leiden University Medical Center

NETHERLANDS
View details

William Polacheck

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Eric Camerer

Team Leader/Research Director

INSERM

FRANCE
View details

Pengchun Yu

Associate Professor

Oklahoma Medical Research Foundation

UNITED STATES
View details

Changcheng Zhou

Professor

University of California Riverside

UNITED STATES
View details

Hiromi Yanagisawa

Professor

University of Tsukuba

JAPAN
View details

Stella Alimperti

Associate Professor

Georgetown University School of Medicine

UNITED STATES
View details

Allon Wagner

University of California, Berkeley

UNITED STATES
View details